REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
24 hedge funds and large institutions have $57.4M invested in REVIVA PHARMA HLDGS INC in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
25% more capital invested
Capital invested by funds: $46.1M → $57.4M (+$11.3M)
4% more funds holding
Funds holding: 23 → 24 (+1)
0.9% more ownership
Funds ownership: 2.66% → 3.56% (+0.9%)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$8.37M |
| 2 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$4.31M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$3.9M |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$3.21M |
| 5 |
MSU
Mizuho Securities USA
New York
|
+$1.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$3.81M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.83M |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$2.71M |
| 4 |
CIM
Cowen Investment Management
New York
|
-$2.16M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$984K |
RVPH Hedge Fund Activity: Q1 2020 in Review
24 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q1 2020, worth a combined $57.4M — up 25% from $46.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new RVPH positions and 4 closed out — a net gain of 1 holder — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Hudson Bay Capital Management, adding an estimated $8.37M. The largest seller was Karpus Investment Management, cutting an estimated $3.81M.
- 24 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q1 2020, up from 23 in Q4 2019.
- Funds reported $57.4M of REVIVA PHARMA HLDGS INC stock for Q1 2020, up 25% quarter-over-quarter.
- 5 funds opened new REVIVA PHARMA HLDGS INC positions in Q1 2020 and 4 closed out, a net change of +1 holder.
- The largest REVIVA PHARMA HLDGS INC buyer in Q1 2020 was Hudson Bay Capital Management, an estimated $8.37M added.
- The largest REVIVA PHARMA HLDGS INC seller in Q1 2020 was Karpus Investment Management, an estimated $3.81M sold.
Based on aggregated 13F filings for Q1 2020.